UniProt ID | GIT1_HUMAN | |
---|---|---|
UniProt AC | Q9Y2X7 | |
Protein Name | ARF GTPase-activating protein GIT1 | |
Gene Name | GIT1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 761 | |
Subcellular Localization | Cytoplasm . Cycles between at least 3 distinct intracellular compartments, including focal adhesions, cytoplasmic complexes and membrane protrusions. During cell migration, when cells detach, moves from the adhesions into the cytoplasmic complexes to | |
Protein Description | GTPase-activating protein for the ADP ribosylation factor family. May serve as a scaffold to bring together molecules to form signaling modules controlling vesicle trafficking, adhesion and cytoskeletal organization. Increases the speed of cell migration, as well as the size and rate of formation of protrusions, possibly by targeting PAK1 to adhesions and the leading edge of lamellipodia. Sequesters inactive non-tyrosine-phosphorylated paxillin in cytoplasmic complexes. Involved in the regulation of cytokinesis; the function may involve SDCCAG3 and PTPN13 (By similarity).. | |
Protein Sequence | MSRKGPRAEVCADCSAPDPGWASISRGVLVCDECCSVHRSLGRHISIVKHLRHSAWPPTLLQMVHTLASNGANSIWEHSLLDPAQVQSGRRKANPQDKVHPIKSEFIRAKYQMLAFVHKLPCRDDDGVTAKDLSKQLHSSVRTGNLETCLRLLSLGAQANFFHPEKGTTPLHVAAKAGQTLQAELLVVYGADPGSPDVNGRTPIDYARQAGHHELAERLVECQYELTDRLAFYLCGRKPDHKNGHYIIPQMADSLDLSELAKAAKKKLQALSNRLFEELAMDVYDEVDRRENDAVWLATQNHSTLVTERSAVPFLPVNPEYSATRNQGRQKLARFNAREFATLIIDILSEAKRRQQGKSLSSPTDNLELSLRSQSDLDDQHDYDSVASDEDTDQEPLRSTGATRSNRARSMDSSDLSDGAVTLQEYLELKKALATSEAKVQQLMKVNSSLSDELRRLQREIHKLQAENLQLRQPPGPVPTPPLPSERAEHTPMAPGGSTHRRDRQAFSMYEPGSALKPFGGPPGDELTTRLQPFHSTELEDDAIYSVHVPAGLYRIRKGVSASAVPFTPSSPLLSCSQEGSRHTSKLSRHGSGADSDYENTQSGDPLLGLEGKRFLELGKEEDFHPELESLDGDLDPGLPSTEDVILKTEQVTKNIQELLRAAQEFKHDSFVPCSEKIHLAVTEMASLFPKRPALEPVRSSLRLLNASAYRLQSECRKTVPPEPGAPVDFQLLTQQVIQCAYDIAKAAKQLVTITTREKKQ | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
23 | Phosphorylation | APDPGWASISRGVLV CCCCCCCCCCCCEEE | 18.00 | 27251275 | |
25 | Phosphorylation | DPGWASISRGVLVCD CCCCCCCCCCEEECH | 22.08 | 27251275 | |
36 | Phosphorylation | LVCDECCSVHRSLGR EECHHHHHHHHHHHH | 32.39 | 27251275 | |
46 | Phosphorylation | RSLGRHISIVKHLRH HHHHHHHHHHHHHHH | 18.40 | 24719451 | |
49 | Ubiquitination | GRHISIVKHLRHSAW HHHHHHHHHHHHCCC | 34.94 | - | |
49 (in isoform 3) | Ubiquitination | - | 34.94 | - | |
54 | Phosphorylation | IVKHLRHSAWPPTLL HHHHHHHCCCCHHHH | 26.12 | - | |
103 | Ubiquitination | QDKVHPIKSEFIRAK CCCCCCCHHHHHHHH | 48.67 | - | |
104 | Phosphorylation | DKVHPIKSEFIRAKY CCCCCCHHHHHHHHH | 38.16 | 29514088 | |
111 | Phosphorylation | SEFIRAKYQMLAFVH HHHHHHHHHHHHHHH | 9.73 | 29759185 | |
119 | Acetylation | QMLAFVHKLPCRDDD HHHHHHHCCCCCCCC | 49.15 | 25953088 | |
134 | Phosphorylation | GVTAKDLSKQLHSSV CCCHHHHHHHHHHHH | 28.61 | 17287340 | |
135 | Ubiquitination | VTAKDLSKQLHSSVR CCHHHHHHHHHHHHH | 65.26 | - | |
135 (in isoform 3) | Malonylation | - | 65.26 | 26320211 | |
135 (in isoform 3) | Ubiquitination | - | 65.26 | - | |
139 | Phosphorylation | DLSKQLHSSVRTGNL HHHHHHHHHHHHCCH | 38.84 | 28857561 | |
154 | Phosphorylation | ETCLRLLSLGAQANF HHHHHHHHHCCCCEE | 29.37 | 28857561 | |
166 | Acetylation | ANFFHPEKGTTPLHV CEEECCCCCCCCHHH | 67.04 | 25953088 | |
168 | Phosphorylation | FFHPEKGTTPLHVAA EECCCCCCCCHHHHH | 35.99 | - | |
169 | Phosphorylation | FHPEKGTTPLHVAAK ECCCCCCCCHHHHHH | 32.30 | - | |
202 | Phosphorylation | SPDVNGRTPIDYARQ CCCCCCCCHHHHHHH | 26.45 | 21712546 | |
224 | Phosphorylation | ERLVECQYELTDRLA HHHHHHHHHHHHHHH | 25.27 | 28152594 | |
227 | Phosphorylation | VECQYELTDRLAFYL HHHHHHHHHHHHHHH | 13.72 | 28152594 | |
246 | Phosphorylation | PDHKNGHYIIPQMAD CCCCCCCCCHHHCCC | 11.27 | 30576142 | |
254 | Phosphorylation | IIPQMADSLDLSELA CHHHCCCCCCHHHHH | 17.78 | 28348404 | |
258 | Phosphorylation | MADSLDLSELAKAAK CCCCCCHHHHHHHHH | 30.17 | 30576142 | |
261 | Phosphorylation | SLDLSELAKAAKKKL CCCHHHHHHHHHHHH | 8.73 | - | |
261 (in isoform 3) | Phosphorylation | - | 8.73 | 22817900 | |
263 | Phosphorylation | DLSELAKAAKKKLQA CHHHHHHHHHHHHHH | 20.93 | - | |
263 (in isoform 3) | Phosphorylation | - | 20.93 | 22817900 | |
284 | Phosphorylation | EELAMDVYDEVDRRE HHHHHHHHHHHHHHH | 11.34 | 16825424 | |
293 | Phosphorylation | EVDRRENDAVWLATQ HHHHHHCCCEEEECC | 37.43 | - | |
303 | Phosphorylation | WLATQNHSTLVTERS EEECCCCCCCEECCC | 30.87 | 28857561 | |
304 | Phosphorylation | LATQNHSTLVTERSA EECCCCCCCEECCCC | 20.07 | 28857561 | |
307 | Phosphorylation | QNHSTLVTERSAVPF CCCCCCEECCCCCCC | 28.88 | 28857561 | |
321 | Phosphorylation | FLPVNPEYSATRNQG CCCCCHHHCCCCCHH | 12.59 | 20689073 | |
322 | Phosphorylation | LPVNPEYSATRNQGR CCCCHHHCCCCCHHH | 22.85 | 28348404 | |
324 | Phosphorylation | VNPEYSATRNQGRQK CCHHHCCCCCHHHHH | 24.98 | 28348404 | |
333 | Phosphorylation | NQGRQKLARFNAREF CHHHHHHHHHHHHHH | 22.51 | 27251275 | |
358 | Ubiquitination | AKRRQQGKSLSSPTD HHHHHCCCCCCCCCC | 43.83 | - | |
359 | Phosphorylation | KRRQQGKSLSSPTDN HHHHCCCCCCCCCCC | 40.06 | 30266825 | |
361 | Phosphorylation | RQQGKSLSSPTDNLE HHCCCCCCCCCCCHH | 41.17 | 29255136 | |
362 | Phosphorylation | QQGKSLSSPTDNLEL HCCCCCCCCCCCHHH | 36.79 | 29255136 | |
364 | Phosphorylation | GKSLSSPTDNLELSL CCCCCCCCCCHHHHC | 39.19 | 29255136 | |
370 | Phosphorylation | PTDNLELSLRSQSDL CCCCHHHHCCCCCCC | 16.62 | 25159151 | |
371 | Phosphorylation | TDNLELSLRSQSDLD CCCHHHHCCCCCCCC | 10.77 | 24719451 | |
373 | Phosphorylation | NLELSLRSQSDLDDQ CHHHHCCCCCCCCCC | 39.05 | 23927012 | |
375 | Phosphorylation | ELSLRSQSDLDDQHD HHHCCCCCCCCCCCC | 41.19 | 23927012 | |
379 | Phosphorylation | RSQSDLDDQHDYDSV CCCCCCCCCCCHHHC | 55.82 | 27251275 | |
382 | Phosphorylation | SDLDDQHDYDSVASD CCCCCCCCHHHCCCC | 43.21 | - | |
383 | Phosphorylation | DLDDQHDYDSVASDE CCCCCCCHHHCCCCC | 14.16 | 23927012 | |
384 | Phosphorylation | LDDQHDYDSVASDED CCCCCCHHHCCCCCC | 42.57 | - | |
385 | Phosphorylation | DDQHDYDSVASDEDT CCCCCHHHCCCCCCC | 17.22 | 20201521 | |
388 | Phosphorylation | HDYDSVASDEDTDQE CCHHHCCCCCCCCCC | 39.10 | 20201521 | |
392 | Phosphorylation | SVASDEDTDQEPLRS HCCCCCCCCCCCHHH | 37.22 | 23927012 | |
394 | Phosphorylation | ASDEDTDQEPLRSTG CCCCCCCCCCHHHCC | 57.19 | 24719451 | |
397 | Phosphorylation | EDTDQEPLRSTGATR CCCCCCCHHHCCCCH | 7.13 | 24719451 | |
399 | Phosphorylation | TDQEPLRSTGATRSN CCCCCHHHCCCCHHH | 38.59 | 21406692 | |
400 | Phosphorylation | DQEPLRSTGATRSNR CCCCHHHCCCCHHHC | 25.13 | 21406692 | |
401 | Phosphorylation | QEPLRSTGATRSNRA CCCHHHCCCCHHHCC | 26.63 | - | |
403 | Phosphorylation | PLRSTGATRSNRARS CHHHCCCCHHHCCCC | 35.66 | 30576142 | |
410 | Phosphorylation | TRSNRARSMDSSDLS CHHHCCCCCCHHHCC | 26.42 | 23927012 | |
413 | Phosphorylation | NRARSMDSSDLSDGA HCCCCCCHHHCCCCC | 19.67 | 30266825 | |
414 | Phosphorylation | RARSMDSSDLSDGAV CCCCCCHHHCCCCCE | 38.00 | 30278072 | |
417 | Phosphorylation | SMDSSDLSDGAVTLQ CCCHHHCCCCCEEHH | 38.70 | 30278072 | |
419 | Phosphorylation | DSSDLSDGAVTLQEY CHHHCCCCCEEHHHH | 20.69 | 24719451 | |
422 | Phosphorylation | DLSDGAVTLQEYLEL HCCCCCEEHHHHHHH | 23.38 | 23927012 | |
423 | Phosphorylation | LSDGAVTLQEYLELK CCCCCEEHHHHHHHH | 2.68 | - | |
426 | Phosphorylation | GAVTLQEYLELKKAL CCEEHHHHHHHHHHH | 7.78 | 23403867 | |
448 | Phosphorylation | QQLMKVNSSLSDELR HHHHHHCCHHHHHHH | 35.33 | 22817900 | |
449 | Phosphorylation | QLMKVNSSLSDELRR HHHHHCCHHHHHHHH | 27.04 | 22817900 | |
451 | Phosphorylation | MKVNSSLSDELRRLQ HHHCCHHHHHHHHHH | 30.87 | 27251275 | |
457 | Phosphorylation | LSDELRRLQREIHKL HHHHHHHHHHHHHHH | 4.56 | - | |
458 | Phosphorylation | SDELRRLQREIHKLQ HHHHHHHHHHHHHHH | 38.87 | 27251275 | |
463 | Acetylation | RLQREIHKLQAENLQ HHHHHHHHHHHHHCC | 48.21 | 25953088 | |
480 | Phosphorylation | QPPGPVPTPPLPSER CCCCCCCCCCCCCHH | 37.46 | 30266825 | |
485 | Phosphorylation | VPTPPLPSERAEHTP CCCCCCCCHHCCCCC | 47.61 | 23403867 | |
489 | Phosphorylation | PLPSERAEHTPMAPG CCCCHHCCCCCCCCC | 55.29 | 24719451 | |
491 | Phosphorylation | PSERAEHTPMAPGGS CCHHCCCCCCCCCCC | 13.28 | 20068231 | |
498 | Phosphorylation | TPMAPGGSTHRRDRQ CCCCCCCCCCCCCCC | 27.27 | 23401153 | |
499 | Phosphorylation | PMAPGGSTHRRDRQA CCCCCCCCCCCCCCC | 23.76 | 23401153 | |
500 | Phosphorylation | MAPGGSTHRRDRQAF CCCCCCCCCCCCCCH | 25.19 | 24719451 | |
507 | Phosphorylation | HRRDRQAFSMYEPGS CCCCCCCHHCCCCCC | 3.06 | 27251275 | |
508 | Phosphorylation | RRDRQAFSMYEPGSA CCCCCCHHCCCCCCC | 24.38 | 21945579 | |
510 | Phosphorylation | DRQAFSMYEPGSALK CCCCHHCCCCCCCCC | 20.13 | 21945579 | |
514 | Phosphorylation | FSMYEPGSALKPFGG HHCCCCCCCCCCCCC | 40.94 | 21945579 | |
517 | Methylation | YEPGSALKPFGGPPG CCCCCCCCCCCCCCC | 37.71 | - | |
517 | Phosphorylation | YEPGSALKPFGGPPG CCCCCCCCCCCCCCC | 37.71 | 27251275 | |
519 | Phosphorylation | PGSALKPFGGPPGDE CCCCCCCCCCCCCCH | 19.77 | - | |
536 | Phosphorylation | TRLQPFHSTELEDDA CCCCCCCCCCCCCCC | 24.77 | 22617229 | |
537 | Phosphorylation | RLQPFHSTELEDDAI CCCCCCCCCCCCCCE | 35.70 | 22617229 | |
545 | Phosphorylation | ELEDDAIYSVHVPAG CCCCCCEEEEEECCC | 13.32 | 27273156 | |
546 | Phosphorylation | LEDDAIYSVHVPAGL CCCCCEEEEEECCCH | 10.30 | 27273156 | |
554 | Phosphorylation | VHVPAGLYRIRKGVS EEECCCHHHHCCCCC | 11.77 | 15570572 | |
555 | Phosphorylation | HVPAGLYRIRKGVSA EECCCHHHHCCCCCC | 27.55 | - | |
561 | O-linked_Glycosylation | YRIRKGVSASAVPFT HHHCCCCCCCCCCCC | 25.77 | 28657654 | |
561 | Phosphorylation | YRIRKGVSASAVPFT HHHCCCCCCCCCCCC | 25.77 | 29255136 | |
563 | Phosphorylation | IRKGVSASAVPFTPS HCCCCCCCCCCCCCC | 23.46 | 29255136 | |
568 | Phosphorylation | SASAVPFTPSSPLLS CCCCCCCCCCCCCCC | 19.05 | 29255136 | |
570 | Phosphorylation | SAVPFTPSSPLLSCS CCCCCCCCCCCCCCC | 41.34 | 29255136 | |
571 | Phosphorylation | AVPFTPSSPLLSCSQ CCCCCCCCCCCCCCC | 22.29 | 23401153 | |
572 | Phosphorylation | VPFTPSSPLLSCSQE CCCCCCCCCCCCCCC | 41.48 | 27251275 | |
575 | Phosphorylation | TPSSPLLSCSQEGSR CCCCCCCCCCCCCCC | 21.29 | 29255136 | |
577 | Phosphorylation | SSPLLSCSQEGSRHT CCCCCCCCCCCCCHH | 28.08 | 29255136 | |
579 | Phosphorylation | PLLSCSQEGSRHTSK CCCCCCCCCCCHHHH | 42.73 | 27251275 | |
580 | Phosphorylation | LLSCSQEGSRHTSKL CCCCCCCCCCHHHHH | 23.49 | 24719451 | |
581 | Phosphorylation | LSCSQEGSRHTSKLS CCCCCCCCCHHHHHH | 21.82 | 28348404 | |
584 | Phosphorylation | SQEGSRHTSKLSRHG CCCCCCHHHHHHHCC | 26.84 | 30576142 | |
585 | Phosphorylation | QEGSRHTSKLSRHGS CCCCCHHHHHHHCCC | 26.02 | 30576142 | |
586 | Phosphorylation | EGSRHTSKLSRHGSG CCCCHHHHHHHCCCC | 52.19 | 27251275 | |
588 | Phosphorylation | SRHTSKLSRHGSGAD CCHHHHHHHCCCCCC | 26.43 | 25849741 | |
592 | Phosphorylation | SKLSRHGSGADSDYE HHHHHCCCCCCCCCC | 25.36 | 29255136 | |
594 | Phosphorylation | LSRHGSGADSDYENT HHHCCCCCCCCCCCC | 18.16 | 24719451 | |
596 | Phosphorylation | RHGSGADSDYENTQS HCCCCCCCCCCCCCC | 41.37 | 29255136 | |
598 | Phosphorylation | GSGADSDYENTQSGD CCCCCCCCCCCCCCC | 18.28 | 29255136 | |
601 | Phosphorylation | ADSDYENTQSGDPLL CCCCCCCCCCCCCCC | 16.51 | 23927012 | |
603 | Phosphorylation | SDYENTQSGDPLLGL CCCCCCCCCCCCCCC | 43.03 | 30266825 | |
605 | Phosphorylation | YENTQSGDPLLGLEG CCCCCCCCCCCCCCC | 35.60 | 24719451 | |
607 | Phosphorylation | NTQSGDPLLGLEGKR CCCCCCCCCCCCCHH | 7.63 | - | |
610 | Phosphorylation | SGDPLLGLEGKRFLE CCCCCCCCCCHHHHH | 8.71 | - | |
613 | Ubiquitination | PLLGLEGKRFLELGK CCCCCCCHHHHHCCC | 30.51 | - | |
630 | Phosphorylation | DFHPELESLDGDLDP CCCHHHHHCCCCCCC | 44.37 | 22817900 | |
639 | Phosphorylation | DGDLDPGLPSTEDVI CCCCCCCCCCHHHHH | 3.54 | - | |
670 | Phosphorylation | AQEFKHDSFVPCSEK HHHHCCCCCCCCHHH | 28.06 | 25849741 | |
675 | Phosphorylation | HDSFVPCSEKIHLAV CCCCCCCHHHHHHHH | 35.54 | 23403867 | |
677 | Acetylation | SFVPCSEKIHLAVTE CCCCCHHHHHHHHHH | 21.09 | 11794205 | |
679 | Phosphorylation | VPCSEKIHLAVTEMA CCCHHHHHHHHHHHH | 20.85 | 27251275 | |
700 | Phosphorylation | PALEPVRSSLRLLNA CCCHHHHHHHHHHCH | 33.68 | 16797488 | |
701 | Phosphorylation | ALEPVRSSLRLLNAS CCHHHHHHHHHHCHH | 13.62 | 22817900 | |
708 | Phosphorylation | SLRLLNASAYRLQSE HHHHHCHHHHHHHHH | 25.43 | 21406692 | |
709 | Phosphorylation | LRLLNASAYRLQSEC HHHHCHHHHHHHHHH | 7.34 | - | |
710 | Phosphorylation | RLLNASAYRLQSECR HHHCHHHHHHHHHHH | 14.90 | 21406692 | |
749 | Acetylation | YDIAKAAKQLVTITT HHHHHHHHHHHEEEC | 49.37 | 25953088 | |
753 | Phosphorylation | KAAKQLVTITTREKK HHHHHHHEEECCCCC | 22.62 | 23917254 | |
755 | Phosphorylation | AKQLVTITTREKKQ- HHHHHEEECCCCCC- | 15.50 | 23186163 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
46 | S | Phosphorylation | Kinase | PRKD3 | O94806 | PSP |
246 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
284 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
321 | Y | Phosphorylation | Kinase | PTK2 | Q05397 | GPS |
321 | Y | Phosphorylation | Kinase | SRC | P12931 | PSP |
508 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
700 | S | Phosphorylation | Kinase | PAK1 | Q13153 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GIT1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GIT1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
PLCG1_HUMAN | PLCG1 | physical | 14523024 | |
LIPA4_HUMAN | PPFIA4 | physical | 12629171 | |
LIPA1_HUMAN | PPFIA1 | physical | 12629171 | |
FAK1_HUMAN | PTK2 | physical | 12629171 | |
FAK2_HUMAN | PTK2B | physical | 12629171 | |
PTPRF_HUMAN | PTPRF | physical | 12629171 | |
PAXI_HUMAN | PXN | physical | 12629171 | |
ARBK1_HUMAN | ADRBK1 | physical | 10896954 | |
PCLO_HUMAN | PCLO | physical | 12473661 | |
ARHG7_HUMAN | ARHGEF7 | physical | 12473661 | |
FAK1_HUMAN | PTK2 | physical | 12473661 | |
GIT1_HUMAN | GIT1 | physical | 12473661 | |
GIT2_HUMAN | GIT2 | physical | 12473661 | |
FAK1_HUMAN | PTK2 | physical | 10938112 | |
PTPRZ_HUMAN | PTPRZ1 | physical | 11381105 | |
ARHG6_HUMAN | ARHGEF6 | physical | 10428811 | |
ARHG7_HUMAN | ARHGEF7 | physical | 10428811 | |
ARBK1_HUMAN | ADRBK1 | physical | 9826657 | |
ARBK2_HUMAN | ADRBK2 | physical | 9826657 | |
HD_HUMAN | HTT | physical | 15383276 | |
LRIF1_HUMAN | LRIF1 | physical | 15383276 | |
HAP1_HUMAN | HAP1 | physical | 15383276 | |
SNRPA_HUMAN | SNRPA | physical | 22863883 | |
PKN3_HUMAN | PKN3 | physical | 27173435 | |
NCK5L_HUMAN | NCKAP5L | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362; THR-364; SER-375;TYR-383; SER-385; SER-388; THR-392; SER-410; TYR-545; SER-561;SER-592; SER-596 AND THR-601, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362; TYR-383; SER-388;SER-592 AND TYR-598, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385 AND SER-388, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-362; SER-373; TYR-383;SER-385; SER-388; THR-392; SER-410; SER-592 AND SER-596, AND MASSSPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385; SER-388; SER-592AND TYR-598, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-134, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385; SER-388; SER-592AND TYR-598, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-388, AND MASSSPECTROMETRY. | |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-545, AND MASSSPECTROMETRY. | |
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks."; Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.; Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-545, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-545 AND TYR-554, ANDMASS SPECTROMETRY. | |
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules."; Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.; Mol. Cell. Proteomics 4:1240-1250(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-545, AND MASSSPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-598, AND MASSSPECTROMETRY. |